Evidence map›Paper›PMID 41896741›Full record

ArticleBMC plant biology2026

Integrated transcriptomic and metabolomic analyses reveal distinct molecular and metabolic signatures in fruits and leaves of three Phyllanthus emblica cultivars.

Xiaoling Hao, Hui Wen, Xiaohua Dai, Junru Qu, Liyan Lu, Gao Li, Yewei Tan, Usman Rasheed, Xinrong Li, Kaikai Meng

Abstract read
In one paragraph

Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiaoling Hao *Guangxi Key Laboratory of Quality and Safety Control for Subtropical Fruits, Guangxi Subtropical Crops Research Institute, Nanning, 530001, China.
Hui Wen *Guangxi Key Laboratory of Quality and Safety Control for Subtropical Fruits, Guangxi Subtropical Crops Research Institute, Nanning, 530001, China.
Xiaohua Dai *Guangxi Key Laboratory of Quality and Safety Control for Subtropical Fruits, Guangxi Subtropical Crops Research Institute, Nanning, 530001, China.
Junru QuGuangxi Key Laboratory of Quality and Safety Control for Subtropical Fruits, Guangxi Subtropical Crops Research Institute, Nanning, 530001, China.
Liyan LuGuangxi Key Laboratory of Quality and Safety Control for Subtropical Fruits, Guangxi Subtropical Crops Research Institute, Nanning, 530001, China.
Gao LiGuangxi Xianyou Food Technology Corporate Limited, Baise, 531502, China.
Yewei TanGuangxi Key Laboratory of Quality and Safety Control for Subtropical Fruits, Guangxi Subtropical Crops Research Institute, Nanning, 530001, China.
Usman RasheedGuangxi Key Laboratory of Quality and Safety Control for Subtropical Fruits, Guangxi Subtropical Crops Research Institute, Nanning, 530001, China.
Xinrong LiGuangxi Key Laboratory of Quality and Safety Control for Subtropical Fruits, Guangxi Subtropical Crops Research Institute, Nanning, 530001, China. rzslxr@163.com.
Kaikai MengGuangxi Key Laboratory of Quality and Safety Control for Subtropical Fruits, Guangxi Subtropical Crops Research Institute, Nanning, 530001, China. mengkaikai2024@163.com.

Funding

the Basic Scientific and Research Project of Guangxi Academy of Agricultural Sciences No. 2025YP135the Basic Scientific and Research Project of Guangxi Academy of Agricultural Sciences No. 2025YP140
6 · The paper itself

Abstract

backgroundPhyllanthus emblica L. (Indian gooseberry, amla) is a dual-purpose plant valued for both nutritional and medicinal applications. In recent years, research on P. emblica has mainly concentrated on examining its chemical components and pharmacological effects. Metabolic diversity among different P. emblica varieties has attracted considerable research interest. However, the molecular mechanisms underlying this variation remain largely unexplored. The present study aimed to evaluate the multi-omics differences among varieties by conducting integrated metabolomic and transcriptomic analyses of three major varieties grown in Guangxi: Tianyougan, Pingdan No. 1, and Daguoyougan.

resultsThe results showed that Tianyougan and Pingdan No. 1 had similar expression patterns, significantly differing from Daguoyougan. Tianyougan and Pingdan No. 1 exhibited rich flavor-related metabolite profiles, while Daguoyougan accumulated higher levels of metabolites associated with antioxidant properties and stress response. A total of 150 and 143 differentially accumulated metabolites (DAMs) were identified in fruits and leaves, respectively. These metabolites were predominantly enriched in pathways associated with organic acid metabolism. Specifically, 29 DAMs and 132 DEGs were mapped to the tricarboxylic acid (TCA) cycle, glycolysis/gluconeogenesis, pentose phosphate pathway, amino acid biosynthesis, D-amino acid metabolism, and phenylpropanoid biosynthesis. Among these, PGAM, pfkA, ACO, HK, ilvH, PK, pckA, ALDO, and CS were identified as key DEGs regulating organic acid metabolic divergence across the three varieties. In addition, two genes (TRINITY_DN549104_c2_g2 and TRINITY_DN567014_c3_g3) were screened and showed strong correlations with various differential organic acids, which can serve as potential pleiotropic factors to regulate organic acid metabolism.

conclusionsThis work provides novel insights into the metabolic diversity and molecular regulation of Tianyougan, Pingdan No. 1, and Daguoyougan, offering a theoretical foundation for quality improvement and functional gene discovery in P. emblica.

Indexed as

FruitMetabolomePhyllanthus emblicaPlant LeavesTranscriptomeGene Expression ProfilingMetabolomicsMultiomicsCultivarsMulti-omicsOrganic acid biosynthesisPhyllanthus emblica

Identifiers

PMID41896741
PMCPMC13147830

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.